Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $20.5M | $30.1M | $38.3M | $65.1M | $86.7M | $135.8M | $112.6M | ($382.5M) | ($83.6M) | ($96.2M) | $12.8M | ($3,021.0K) | $37.3M | $30.3M | $119.3M | $126.8M | $183.6M | $209.1M | $118.6M | ($9,747.0K) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Amedisys, Inc.'s last 12-month Net Income is $127.5M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Amedisys, Inc.'s Net Income growth was 4,716.4%. The average annual Net Income growth rates for Amedisys, Inc. have been (14.2%) over the past three years, 0.1% over the past five years.
Over the last year, Amedisys, Inc.'s Net Income growth was 4,716.4%, which is higher than industry growth of 0.3%. It indicates that Amedisys, Inc.'s Net Income growth is Good.